Insight

Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management

Photo from Michael Duruisseaux/X

Apr 11, 2024, 17:17

Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management

Michael Duruisseaux, Medical Director of the Joint Research Unit in Thoracic Oncology of the Hospices Civilians of Lyons, shared on X/Twitter:

“Just out on Lung Cancer Journal!
Based on the experience of two French expert lung cancer teams from Hospices Civils de Lyon and Institut Curie we propose practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management.
Share your opinion!”

Proceed to the article.
Source: Michael Duruisseaux/X

cancer Hospices Civils de Lyon Institut Curie Lung cancer Lung Cancer Journal Michael Duruisseaux OncoDaily Oncology Sotorasib sotorasib-related adverse events

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer